Monte Rosa Therapeutics Growth Metrics (2023-2025) | GLUE

Growth Metrics Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
Assets Growth (1y) -13.68%23.51%24.98%44.44%47.41%4.50%45.94%
Assets (QoQ) -9.84%-9.52%20.49%-12.18%29.00%-8.44%39.24%-10.38%-8.55%27.88%
Capital Expenditures Growth (1y) -84.93%-68.95%-75.95%-89.17%14.67%-16.17%63.16%
Capital Expenditures (QoQ) -29.07%-74.52%1.81%-18.06%46.10%-80.27%-54.14%767.21%6.81%-61.59%
Cash & Equivalents Growth (1y) 92.40%131.46%112.64%61.14%235.91%176.40%219.83%
Cash & Equivalents (QoQ) -9.30%25.58%300.34%-57.81%9.12%15.37%203.38%-12.04%-10.21%33.49%
Cash from Investing Activities Growth (1y) -51.53%-429.69%5.95%-316.10%-1,117.24%141.41%1.03%
Cash from Investing Activities (QoQ) -8.74%92.06%-59.87%-31.08%-720.70%161.72%-181.85%-224.41%125.27%50.60%
Cash from Operations Growth (1y) -63.06%-9.65%15.02%335.05%-19.20%-25.04%578.37%
Cash from Operations (QoQ) -8.19%2.44%219.95%-228.79%27.24%24.39%714.09%-135.29%23.68%389.25%
EBITDA Margin Growth (1y) 305,683.0059,189.004,400.00
EBITDA Margin (QoQ) 235,651.0038,998.0027,556.003,479.00-10844.00-15791.00
EBIT Growth (1y) -2.01%12.30%28.24%137.30%226.01%52.35%-24.31%
EBIT Margin Growth (1y) 333,634.0062,819.002,957.00
EBIT Margin (QoQ) 258,924.0040,741.0030,928.003,041.00-11891.00-19120.00
EBIT (QoQ) -8.65%0.68%5.69%-0.24%6.60%18.73%149.02%238.63%-135.32%-112.00%
EBT Growth (1y) 0.48%14.09%31.47%146.89%249.62%63.08%-27.20%
EBT Margin Growth (1y) 305,288.0059,237.002,113.00
EBT Margin (QoQ) 235,650.0038,210.0028,384.003,045.00-10401.00-18914.00
EBT (QoQ) -9.21%0.78%4.15%4.17%5.73%20.86%165.58%205.79%-123.26%-172.69%
Enterprise Value Growth (1y) -23.47%-72.51%11.68%-2.43%-119.57%-129.28%-71.95%
Enterprise Value (QoQ) -12.19%-38.61%-73.97%445.44%-68.46%149.41%-77.26%-209.40%52.80%338.88%
EPS (Basic) Growth (1y) 18.46%39.44%58.57%140.35%207.55%65.12%-13.79%
EPS (Basic) (QoQ) -9.23%1.41%18.57%7.02%18.87%32.56%179.31%147.83%-126.32%-120.00%
EPS (Weighted Average and Diluted) Growth (1y) 18.46%39.44%58.57%140.35%207.55%65.12%-13.79%
EPS (Weighted Average and Diluted) (QoQ) -9.23%1.41%18.57%7.02%18.87%32.56%179.31%147.83%-126.32%-120.00%
FCF Margin Growth (1y) 366,158.0047,748.00101,359.00
FCF Margin (QoQ) 308,253.0040,235.0044,440.00-26771.00-10157.0093,846.00
Free Cash Flow Growth (1y) -21.36%6.43%18.86%360.69%-19.04%-22.24%566.40%
Free Cash Flow (QoQ) 2.30%17.18%205.99%-241.52%24.68%28.18%701.78%-136.57%22.65%374.00%
Net Cash Flow Growth (1y) -816.59%263.22%39.48%42.73%-419.16%-199.26%728.35%
Net Cash Flow (QoQ) -82.04%315.70%474.77%-140.61%132.42%84.33%488.16%-247.72%93.80%1,638.19%
Net Income Growth (1y) 0.17%13.84%31.60%140.32%246.58%59.44%-13.50%
Net Income (QoQ) -9.80%0.84%4.68%3.81%5.24%21.28%156.19%249.71%-126.22%-120.26%
Net Income towards Common Stockholders Growth (1y) 0.17%13.84%31.60%140.32%246.58%59.44%-13.50%
Net Income towards Common Stockholders (QoQ) -9.80%0.84%4.68%3.81%5.24%21.28%156.19%249.71%-126.22%-120.26%
Net Margin Growth (1y) 306,131.0059,257.004,679.00
Net Margin (QoQ) 236,053.0038,669.0028,099.003,310.00-10821.00-15909.00
Operating Income Growth (1y) -2.01%12.30%28.24%137.30%226.01%52.35%-24.31%
Operating Income (QoQ) -8.65%0.68%5.69%-0.24%6.60%18.73%149.02%238.63%-135.32%-112.00%
Operating Margin Growth (1y) 333,634.0062,819.002,957.00
Operating Margin (QoQ) 258,924.0040,741.0030,928.003,041.00-11891.00-19120.00
Profit After Tax Growth (1y) 0.22%13.84%31.60%140.35%246.66%59.44%-13.50%
Profit After Tax (QoQ) -9.80%0.84%4.54%4.00%5.19%21.28%156.32%248.92%-126.22%-120.26%
Property, Plant & Equipment (Net) Growth (1y) 0.69%-5.90%-10.15%-12.78%-13.81%-12.63%-12.23%
Property, Plant & Equipment (Net) (QoQ) 4.53%-0.97%-3.40%0.69%-2.31%-5.44%-6.23%-0.50%-0.97%-5.00%
Return on Assets Growth (1y) 29.0049.0049.0041.00
Return on Assets (QoQ) 1.005.006.0017.0021.005.00-1.00
Return on Capital Employed Growth (1y) 25.0058.0057.0047.00
Return on Capital Employed (QoQ) 3.006.008.008.0036.005.00-2.00
Return on Equity Growth (1y) 40.0084.0078.0064.00
Return on Equity (QoQ) -7.0012.0014.0022.0036.006.00-1.00
Return on Invested Capital (QoQ) 5.00-2.00
Return on Sales (QoQ) 100.0010.00-2.00
Revenue Growth (1y) 7,882.05%394.01%38.54%
Revenue (QoQ) 341.26%96.29%558.06%40.04%-72.69%-44.95%
Share-based Compensation Growth (1y) 22.62%8.40%-4.16%9.70%8.72%8.71%1.91%
Share-based Compensation (QoQ) 4.50%7.58%-8.82%19.61%-7.61%-4.89%4.37%18.55%-7.63%-10.83%
Shareholder's Equity Growth (1y) -37.42%5.16%11.34%24.37%80.41%19.32%19.65%
Shareholder's Equity (QoQ) -12.34%-13.63%-2.86%-14.91%47.31%-8.55%8.51%23.43%-2.57%-8.30%
Tax Rate Growth (1y) 1,400.00
Tax Rate (QoQ) -1234.00